300363.SZ · 博腾股份
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 22.60 CNY |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 95 / 95 / 51 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 43 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +2.0% |
| Distance from 52-week high | +23.2% |
| Market cap (USD) | $1.9B |